Brigitte Robertson, MD
- 3Articles
- 19.5KReads
- 2007–2020Active
- 14Collaborators
- 8Citations
About
Brigitte Robertson, MD, has published research on the treatment of neurodevelopmental and psychiatric conditions, including major depressive disorder, eating disorders, and ADHD. Her work has examined the effects of pharmacologic treatments such as lisdexamfetamine dimesylate on executive function and withdrawal symptoms in adults with ADHD and binge-eating disorder. She has also investigated the impact of bupropion extended release on emotional processing in depression using functional magnetic resonance imaging. Her publications span from 2007 to 2020 in Psychiatrist.com journals.
Publications
Relationships Between Executive Function and ADHD Symptom Improvement With Lisdexamfetamine
May 28, 2020
Amphetamine Withdrawal After Lisdexamfetamine Cessation
March 26, 2020
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
